Chinese Journal of Cancer Research最新文献

筛选
英文 中文
Comments on Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version) 中国黑色素瘤诊疗指南2018(英文版)
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-10-01 DOI: 10.21147/j.issn.1000-9604.2019.05.03
X. Bai, L. Mao, Jun Guo
{"title":"Comments on Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)","authors":"X. Bai, L. Mao, Jun Guo","doi":"10.21147/j.issn.1000-9604.2019.05.03","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.05.03","url":null,"abstract":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China Correspondence to: Jun Guo. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China. Email: guoj307@126.com.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44144269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China 中国城乡基层医疗卫生机构癌症筛查服务能力研究
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-10-01 DOI: 10.21147/j.issn.1000-9604.2019.05.13
Yang Li, Li Ma, Chunxia Yang, Zhang Chen, Yuqian Zhao, L. Dang, J. Lang, Y. Qiao
{"title":"A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China","authors":"Yang Li, Li Ma, Chunxia Yang, Zhang Chen, Yuqian Zhao, L. Dang, J. Lang, Y. Qiao","doi":"10.21147/j.issn.1000-9604.2019.05.13","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.05.13","url":null,"abstract":"Objective To provide a decision-making basis for sustainable and effective development of cervical cancer screening. Methods This cross-sectional study assesses the service capacity to conduct cervical cancer screening with a sample of 310 medical staff, medical institutions and affiliated township health centers from 20 county-level/district-level areas in 14 Chinese provinces in 2016. Results The county-level/district-level institutions were the main prescreening institutions for cervical cancer screening. More medical staff have become engaged in screening, with a significantly higher amounts in urban than in rural areas (P<0.05). The number of human papillomavirus (HPV) testers grew the fastest (by 225% in urban and 125% in rural areas) over the course of the project. HPV testing took less time than cytology to complete the same number of screening tasks in both urban and rural areas. The proportion of mid-level professionals was the highest among the medical staff, 40.0% in urban and 44.7% in rural areas (P=0.406), and most medical staff had a Bachelor’s degree, accounting for 76.3% in urban and 52.0% in rural areas (P<0.001). In urban areas, 75.0% were qualified medical staff, compared with 68.0% in rural areas, among which the lowest proportion was observed for rural cytology inspectors (22.7%). The medical equipment for cervical pathology diagnosis in urban areas was better (P<0.001). HPV testing equipment was relatively adequate (typing test equipment was 70% in urban areas, and non-typing testing equipment was 70% in rural areas). Conclusions The service capacity of cervical cancer screening is insufficient for the health needs of the Chinese population. HPV testing might be an optimal choice to fill the needs of cervical cancer screening given current Chinese medical health service capacity.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47371415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Machine-learning-assisted prediction of surgical outcomes in patients undergoing gastrectomy 机器学习辅助预测胃切除术患者的手术结果
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-10-01 DOI: 10.21147/j.issn.1000-9604.2019.05.09
Sheng Lu, M. Yan, Chen Li, Chao Yan, Zheng‐gang Zhu, Wencong Lu
{"title":"Machine-learning-assisted prediction of surgical outcomes in patients undergoing gastrectomy","authors":"Sheng Lu, M. Yan, Chen Li, Chao Yan, Zheng‐gang Zhu, Wencong Lu","doi":"10.21147/j.issn.1000-9604.2019.05.09","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.05.09","url":null,"abstract":"Objective Postoperative complications adversely affected the prognosis in patients with gastric cancer. This study intends to investigate the feasibility of using machine-learning model to predict surgical outcomes in patients undergoing gastrectomy. Methods In this study, cancer patients who underwent gastrectomy at Shanghai Rui Jin Hospital in 2017 were randomly assigned to a development or validation cohort in a 9:1 ratio. A support vector classification (SVC) model to predict surgical outcomes in patients undergoing gastrectomy was developed and further validated. Results A total of 321 patients with 32 features were collected. The positive and negative outcomes of postoperative complication after gastrectomy appeared in 100 (31.2%) and 221 (68.8%) patients, respectively. The SVC model was constructed to predict surgical outcomes in patients undergoing gastrectomy. The accuracy of 10-fold cross validation and external verification was 78.17% and 78.12%, respectively. Further, an online web server has been developed to share the SVC model for machine-learning-assisted prediction of surgical outcomes in patients undergoing gastrectomy in the future procedures, which is accessible at the web address: http://47.100.47.97:5005/r_model_prediction. Conclusions The SVC model was a useful predictor for measuring the risk of postoperative complications after gastrectomy, which may help stratify patients with different overall status for choice of surgical procedure or other treatments. It can be expected that machine-learning models in cancer informatics research are possibly shareable and accessible via web address all over the world.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44062669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Effect of intraoperative fluid administration on perioperative outcomes in patients undergoing McKeown esophagogastrectomy 术中给液对McKeown食管胃切除术患者围手术期预后的影响
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-10-01 DOI: 10.21147/j.issn.1000-9604.2019.05.04
Hongliang Wu, Wen Wang, Gefei Zhao, Q. Xue
{"title":"Effect of intraoperative fluid administration on perioperative outcomes in patients undergoing McKeown esophagogastrectomy","authors":"Hongliang Wu, Wen Wang, Gefei Zhao, Q. Xue","doi":"10.21147/j.issn.1000-9604.2019.05.04","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.05.04","url":null,"abstract":"Objective Fluid therapy is one of the key components of perioperative management. However, evidence of intraoperative fluid (IOF) administration affecting clinical outcomes following McKeown esophagogastrectomy remains limited. This study investigated the impact of IOF on clinical outcomes after McKeown esophagogastrectomy. Methods Patients who underwent McKeown esophagogastrectomy between July 2013 and July 2016 were identified. Preoperative, intraoperative and postoperative variables for each eligible patient were retrospectively collected from our electronic medical records and anesthetic records. IOF rates were determined and their relationships to postoperative clinical outcomes were compared. Results A total of 546 patients were enrolled in the analysis. The median IOF rate was 8.87 mL/kg/h. We divided the patients into two groups: a low fluid volume group (LFVG <8.87 mL/kg/h, n=273) and a high fluid volume group (HFVG ≥8.87 mL/kg/h, n=273). No statistically significant differences in postoperative clinical outcomes were found between LFVG and HFVG either before or after propensity score matching. Conclusions No effect of IOF administration on clinical outcomes in patients undergoing McKeown esophagogastrectomy was identified. Further high-quality studies examining the influence of IOF administration on clinical outcomes following McKeown esophagogastrectomy are still needed.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47299661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical outcomes of hand-assisted laparoscopic liver resection vs. open liver resection: A retrospective propensity score-matched cohort study 手助腹腔镜肝切除术与开放性肝切除术的手术结果:一项回顾性倾向评分匹配队列研究
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-10-01 DOI: 10.21147/j.issn.1000-9604.2019.05.11
Shengtao Lin, Fan Wu, Liming Wang, Yunhe Liu, Yiling Zheng, Tana Siqin, W. Rong, Jianxiong Wu
{"title":"Surgical outcomes of hand-assisted laparoscopic liver resection vs. open liver resection: A retrospective propensity score-matched cohort study","authors":"Shengtao Lin, Fan Wu, Liming Wang, Yunhe Liu, Yiling Zheng, Tana Siqin, W. Rong, Jianxiong Wu","doi":"10.21147/j.issn.1000-9604.2019.05.11","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.05.11","url":null,"abstract":"Objective Hand-assisted laparoscopic liver resection has the advantages of open and laparoscopic surgeries. There is still lack of comparison of surgical outcomes between hand-assistied laparoscopic liver resection (HALLR) and open liver resection (OLR). This study compared the surgical outcomes of the two approaches between well-matched patient cohorts. Methods Patients who received liver resection during January 2014 and October 2017 in Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College were included in this retrospective study. Propensity score matching (PSM) was performed to reduce selection bias between the two groups. Operation and short-term surgical outcomes were compared between the well matched groups. Results During this period, 232 patients with a median age of 55.1 years old received OLR, while 49 patients with a median age of 54.7 years old received HALLR. Compared with HALLR group, OLR group has a higher proportion in male patients (190/232, 81.9% vs. 34/49, 69.4%, P=0.048) and lower albumin (43.2±4.5 vs. 44.8±3.7, P=0.020). After PSM, 49 patients from each group were included in the following analysis. Two groups were well balanced in their baseline characteristics, liver functions, preoperative treatments, abdominal surgery history, and surgical difficulty. None perioperative mortality was observed in both groups. Operation time and postoperative complications were similar in two groups (P=0.935, P=0.056). The HALLR group showed less bleeding amount (177.8±217.1 mL vs. 283.1±225.0 mL, P=0.003) and shorter postoperative stay period (6.9±2.2 d vs. 9.0±3.5 d, P=0.001). Conclusions We demonstrated that hand-assisted laparoscopic surgery is feasible and safe for liver resection, including some difficult cases. HALLR can provide better bleeding control and faster recovery after surgery.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46371710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Association of cancer prevention awareness with esophageal cancer screening participation rates: Results from a population-based cancer screening program in rural China 癌症预防意识与食管癌症筛查参与率的关系:中国农村基于人群的癌症筛查项目的结果
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-08-01 DOI: 10.21147/j.issn.1000-9604.2019.04.04
Shangchun Jia, He Li, H. Zeng, R. Zheng, Jiang Li, Jufang Shi, Zhixun Yang, M. Cao, Wanqing Chen
{"title":"Association of cancer prevention awareness with esophageal cancer screening participation rates: Results from a population-based cancer screening program in rural China","authors":"Shangchun Jia, He Li, H. Zeng, R. Zheng, Jiang Li, Jufang Shi, Zhixun Yang, M. Cao, Wanqing Chen","doi":"10.21147/j.issn.1000-9604.2019.04.04","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.04.04","url":null,"abstract":"Objective China have implemented population-based esophageal cancer (EC) screening programs, however, the participant rates were relatively low. This study was conducted to examine the association between cancer prevention knowledge and EC screening participation rates (PRs). Methods Data in the analyses were obtained from a population-based cancer screening program in four provinces in China since 2007. In the course of 2007−2016, participants who were evaluated as high risk for EC and subsequently recommended for endoscopy examination were included in the final analysis. One-way analysis of variance test, Chi-square test and logistic regression analysis were applied. Results A total of 28,543 individuals assessed as high-risk population for EC were included in this study, with 13,036 males (45.67%) and 15,507 females (54.33%). The prevalence rates of current smoking and alcohol drinking were higher in males (58.25% and 44.22%, respectively) than in females (5.35% and 4.05%, respectively). Participants of females, and those who had older age, lower income, as well as higher education level and cancer prevention knowledge level were more likely to undergo endoscopy. Multivariable analysis showed that higher cancer prevention knowledge was associated with higher PR for endoscopic screening [adjusted odd ratio (aORQ4/Q1) =1.511, 95% confidence interval (95% CI): 1.398−1.632] among our study subjects. This association between cancer prevention knowledge and compliance with endoscopic screening also tends to be strong within subgroups of males, females, aged below 60 years, aged 60 years and above, and lower level of education (illiterate individuals and those with junior high education or less). Conclusions Our results displayed a positive relationship between cancer prevention knowledge and PRs for endoscopic screening, implying cancer prevention awareness being an independent influence factor for compliance with EC screening. Promoting public campaigns about comprehensive knowledge of cancer prevention seemed to be a reasonable and effective strategy to improve population PRs for EC screening.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47872055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China 华北农村高危人乳头瘤病毒基因型流行分布及宫颈癌前病变归因
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-08-01 DOI: 10.21147/j.issn.1000-9604.2019.04.10
Shuang Zhao, Xuelian Zhao, Shangying Hu, Jessica Lu, X. Duan, Xun Zhang, Feng Chen, F. Zhao
{"title":"Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China","authors":"Shuang Zhao, Xuelian Zhao, Shangying Hu, Jessica Lu, X. Duan, Xun Zhang, Feng Chen, F. Zhao","doi":"10.21147/j.issn.1000-9604.2019.04.10","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.04.10","url":null,"abstract":"Objective Precise prevention is more desired for cervical cancer due to the huge population, high prevalence of human papillomavirus (HPV) infection in China and the vision of screen-and-treat strategies in low- and middle-income countries (LMICs). Considerations of combining type-specific prevalence and attribution proportion to high-grade cervical intraepithelial neoplasia are informative to more precise and effective region-specific cervical cancer prevention and control programs. The aim of the current study was to determine the genotype distribution of HPV and attribution to cervical precancerous lesions among women from rural areas in North China. Methods A total of 9,526 women participated in the cervical cancer screening project in rural China. The samples of women who tested positive for HPV were retested with a polymerase chain reaction (PCR)-based HPV genotyping test. The attribution proportion of specific high-risk human papillomavirus (HR-HPV) types for different grades of cervical lesions was calculated by using the type contribution weighting method. Results A total of 22.2% (2,112/9,526) of women were HR-HPV positive and HPV52 (21.7%) was the most common HR-HPV genotype, followed by HPV58 (18.2%), HPV53 (18.2%) and HPV16 (16.2%). The top three genotypes detected in HR-HPV-positive cervical intraepithelial neoplasia (CIN)1 were HPV16 (36.7%), HPV58 (20.4%), HPV56 (15.3%). Among CIN2+, the most frequent genotypes were HPV16 (75.6%), HPV52 (17.8%), HPV58 (16.7%). HPV16, 56, 58, 53, 52, 59, 68, and 18 combined were attributed to 84.17% of all CIN1 lesions, and HPV16, 58, and 52 combined were attributed to 86.98% of all CIN2+ lesions. Conclusions The prevalence of HR-HPV infection among women from rural areas in North China was high and HPV16, HPV58, HPV52 had paramount attributable fraction in CIN2+. Type-specific HPV prevalence and attribution proportion to cervical precancerous lesions should be taken into consideration in the development of vaccines and strategy for screening in this population.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46346278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version) 中国恶性淋巴瘤诊疗指南2018(英文版)
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-08-01 DOI: 10.21147/j.issn.1000-9604.2019.04.01
National Health Commission of PRC
{"title":"Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018 (English version)","authors":"National Health Commission of PRC","doi":"10.21147/j.issn.1000-9604.2019.04.01","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.04.01","url":null,"abstract":"1. Overview 2. Diagnosis of lymphoma 2.1 Clinical manifestations 2.2 Physical examination 2.3 Laboratory examination 2.4 Imaging examination 2.4.1 CT 2.4.2 MRI 2.4.3 PET-CT 2.4.4 Ultrasound 2.4.5 Isotope bone scan 2.5 Other specific examinations 2.6 Pathological examinations 2.6.1 Morphology 2.6.2 IHC 2.6.3 Fluorescence in situ hybridization (FISH) 2.6.4 Antigen receptor gene rearrangement of lymphocytes 2.6.5 Others 3. Staging of lymphoma 4. Radiotherapy of lymphoma 5. Summary of comprehensive treatment of lymphoma 6. Treatment of lymphoma with Traditional Chinese Medicine 7. Clinical features, diagnosis and treatment of common lymphoma pathological types 7.1 HL 7.1.1 Clinical features 7.1.2 Pathological classification and diagnosis 7.1.3 Treatment principles 7.1.4 Prognostic factors of HL 7.2 NHL 7.2.1 DLBCL 7.2.2 FL 7.2.3 MZL 7.2.4 CLL/SLL 7.2.5 MCL 7.2.6 BL 7.2.7 Lymphoblastic lymphoma (LBL) 7.2.8 Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) 7.2.9 Mycosis fungoides/Sézary syndrome, MF/SS 7.2.10 ENKTL 1. Overview","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43320854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
An enrichment model using regular health examination data for early detection of colorectal cancer 利用定期健康检查数据建立早期发现结直肠癌的富集模型
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-08-01 DOI: 10.21147/j.issn.1000-9604.2019.04.12
Q. Shi, Zhaoya Gao, Pengze Wu, Fanxiu Heng, F. Lei, Yanzhao Wang, Q. Gao, Qingmin Zeng, P. Niu, Cheng Li, J. Gu
{"title":"An enrichment model using regular health examination data for early detection of colorectal cancer","authors":"Q. Shi, Zhaoya Gao, Pengze Wu, Fanxiu Heng, F. Lei, Yanzhao Wang, Q. Gao, Qingmin Zeng, P. Niu, Cheng Li, J. Gu","doi":"10.21147/j.issn.1000-9604.2019.04.12","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.04.12","url":null,"abstract":"Objective Challenges remain in current practices of colorectal cancer (CRC) screening, such as low compliance, low specificities and expensive cost. This study aimed to identify high-risk groups for CRC from the general population using regular health examination data. Methods The study population consist of more than 7,000 CRC cases and more than 140,000 controls. Using regular health examination data, a model detecting CRC cases was derived by the classification and regression trees (CART) algorithm. Receiver operating characteristic (ROC) curve was applied to evaluate the performance of models. The robustness and generalization of the CART model were validated by independent datasets. In addition, the effectiveness of CART-based screening was compared with stool-based screening. Results After data quality control, 4,647 CRC cases and 133,898 controls free of colorectal neoplasms were used for downstream analysis. The final CART model based on four biomarkers (age, albumin, hematocrit and percent lymphocytes) was constructed. In the test set, the area under ROC curve (AUC) of the CART model was 0.88 [95% confidence interval (95% CI), 0.87−0.90] for detecting CRC. At the cutoff yielding 99.0% specificity, this model’s sensitivity was 62.2% (95% CI, 58.1%−66.2%), thereby achieving a 63-fold enrichment of CRC cases. We validated the robustness of the method across subsets of test set with diverse CRC incidences, aging rates, genders ratio, distributions of tumor stages and locations, and data sources. Importantly, CART-based screening had the higher positive predictive value (1.6%) than fecal immunochemical test (0.3%). Conclusions As an alternative approach for the early detection of CRC, this study provides a low-cost method using regular health examination data to identify high-risk individuals for CRC for further examinations. The approach can promote early detection of CRC especially in developing countries such as China, where annual health examination is popular but regular CRC-specific screening is rare.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46097952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress? 贝伐单抗治疗癌症潜在益处的生物标志物更新:我们取得进展了吗?
IF 5.1 2区 医学
Chinese Journal of Cancer Research Pub Date : 2019-08-01 DOI: 10.21147/j.issn.1000-9604.2019.04.03
Xu Liang, Huiping Li, F. Coussy, C. Callens, F. Lerebours
{"title":"An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress?","authors":"Xu Liang, Huiping Li, F. Coussy, C. Callens, F. Lerebours","doi":"10.21147/j.issn.1000-9604.2019.04.03","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2019.04.03","url":null,"abstract":"As the first monoclonal antibody against vascular endothelial growth factor (VEGF), bevacizumab (BEV) is a definitely controversial antiangiogenic therapy in breast cancer. The initial excitement over improvements in progression-free survival (PFS) with BEV was tempered by an absence of overall survival (OS) benefit and serious adverse effects. Missing targeted population urged us to identify the predictive biomarkers for BEV efficacy. In this review we focus on the research in breast cancer and provide recent investigations on clinical, radiological, molecular and gene profiling markers of BEV efficacy, including the new results from randomized phase III clinical trials evaluating the efficacy of BEV in combination with comprehensive biomarker analyses. Current evidences indicate some predictive values for genetic variants, molecular imaging, VEGF pathway factors or associated factors in peripheral blood and gene profiling. The current challenge is to validate those potential biomarkers and implement them into clinical practice.","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":5.1,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42610393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信